In this study, we analyzed the relationship between the expression of KK-LC-1 and the prognosis of liver cancer patients by detecting the expression of KK-LC-1 and its corresponding antibodies in serum, aiming to find biomarkers that can predict the prognosis of immunotherapy in liver cancer patients, and further explore its mechanism. This evidence concerns the gene CT83 and liver cancer.